ARTICLE | Company News
Synaptic, Kissei Pharmaceutical deal
January 31, 2000 8:00 AM UTC
In a three-year collaboration, SNAP will use its genomics technologies to identify receptor targets and develop assays for Kissei. SNAP will receive license fees, research funding, milestones and roya...